Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin

被引:121
作者
Shimodaira, H
Yoshioka-Yamashita, A
Kolodner, RD
Wang, JYJ
机构
[1] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA
关键词
D O I
10.1073/pnas.0438031100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mismatch repair (MMR) proteins contribute to genome integrity by correcting replication errors. In higher eukaryotes, MMR proteins also regulate the cellular response to DNA lesions such as oxidized, alkylated, or crosslinked bases. Previous studies have linked MMR proteins to the activation of apoptosis through p53-dependent and p53-independent mechanisms. MMR-deficient cells exhibit variable defects in the induction of p53 and its related p73, which are activators of apoptosis. However, the specific role of each MMR protein in the regulation of apoptosis has not been determined. Here, we describe an interaction between PMS2, an MMR protein, and p73. This interaction causes the stabilization of p73 and the redistribution of PMS2 to the nuclear compartment. Exposure to cisplatin enhances the association between PMS2 and p73. Moreover, stimulation of the p73 proapoptotic function by cisplatin requires PMS2. These results suggest that PMS2 contributes to genome integrity not only through DNA repair but also by enhancing DNA damage-induced apoptosis.
引用
收藏
页码:2420 / 2425
页数:6
相关论文
共 50 条
[1]   CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER [J].
AALTONEN, LA ;
PELTOMAKI, P ;
LEACH, FS ;
SISTONEN, P ;
PYLKKANEN, L ;
MECKLIN, JP ;
JARVINEN, H ;
POWELL, SM ;
JEN, J ;
HAMILTON, SR ;
PETERSEN, GM ;
KINZLER, KW ;
VOGELSTEIN, B ;
DELACHAPELLE, A .
SCIENCE, 1993, 260 (5109) :812-816
[2]  
Aebi S, 1996, CANCER RES, V56, P3087
[3]  
Agami R, 1999, NATURE, V399, P809
[4]   MALE-MICE DEFECTIVE IN THE DNA MISMATCH REPAIR GENE PMS2 EXHIBIT ABNORMAL CHROMOSOME SYNAPSIS IN MEIOSIS [J].
BAKER, SM ;
BRONNER, CE ;
ZHANG, L ;
PLUG, AW ;
ROBATZEK, M ;
WARREN, G ;
ELLIOTT, EA ;
YU, JA ;
ASHLEY, T ;
ARNHEIM, N ;
FLAVELL, RA ;
LISKAY, RM .
CELL, 1995, 82 (02) :309-319
[5]   Functional interactions and signaling properties of mammalian DNA mismatch repair proteins [J].
Bellacosa, A .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (11) :1076-1092
[6]   The mismatch repair system is required for S-phase checkpoint activation [J].
Brown, KD ;
Rathi, A ;
Kamath, R ;
Beardsley, DI ;
Zhan, QM ;
Mannino, JL ;
Baskaran, R .
NATURE GENETICS, 2003, 33 (01) :80-84
[7]   Steady-state regulation of the human DNA mismatch repair system [J].
Chang, DK ;
Ricciardiello, L ;
Goel, A ;
Chang, CL ;
Boland, CR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :18424-18431
[8]   DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes [J].
Costanzo, A ;
Merlo, P ;
Pediconi, N ;
Fulco, M ;
Sartorelli, V ;
Cole, PA ;
Fontemaggi, G ;
Fanciulli, M ;
Schiltz, L ;
Blandino, G ;
Balsano, C ;
Levrero, M .
MOLECULAR CELL, 2002, 9 (01) :175-186
[9]   Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene [J].
De Rosa, M ;
Fasano, C ;
Panariello, L ;
Scarano, MI ;
Belli, G ;
Iannelli, A ;
Ciciliano, F ;
Izzo, P .
ONCOGENE, 2000, 19 (13) :1719-1723
[10]   INACTIVATION OF THE MOUSE MSH2 GENE RESULTS IN MISMATCH REPAIR DEFICIENCY, METHYLATION TOLERANCE, HYPERRECOMBINATION, AND PREDISPOSITION TO CANCER [J].
DEWIND, N ;
DEKKER, M ;
BERNS, A ;
RADMAN, M ;
RIELE, HT .
CELL, 1995, 82 (02) :321-330